Last reviewed · How we verify
NCT07160036: AO-SLO
Repeatability of AO-SLO (Mona IIa) Technology and Cone Cell Density of Individuals Use Repeated Low-level Red-light Therapy
NA trial testing RLRL(Model RS-200-2A, Eyerising; Suzhou Xuanjia Optoelectronic Technology Co., Ltd., Suzhou, China)) in Myopia in 180 participants. Currently enrolling.
20 November 2025
Quick facts
| Lead sponsor | Ruihua Wei |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | quadruple |
| Primary purpose | treatment |
| Enrollment | 180 |
| Start date | 20 September 2025 |
| Primary completion | 20 November 2025 |
| Estimated completion | 20 December 2025 |
| Sites | 1 location across China |
Drugs / interventions tested
- RLRL(Model RS-200-2A, Eyerising; Suzhou Xuanjia Optoelectronic Technology Co., Ltd., Suzhou, China))
Conditions studied
- Myopia — all drugs for Myopia →
Sponsor
Ruihua Wei — full company profile →
Who can join
Adults 6 to 55, any sex, with Myopia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To explore the repeatability of AO-SLO (Mona IIa) technology and the difference of cone cell density between individuals who used or not used repeated low-intensity red light treatment
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07160036
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Myopia
Currently open trials in the same condition.
- NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
- NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
- NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
- NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
- NCT07229365 — Children's Viewing Behavior · NA · recruiting
Other Ruihua Wei trials
Trials by the same sponsor.
- NCT07186088 — Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencies · NA · not yet recruiting
- NCT06523504 — Atropine (0.02%, 0.04%) Combined With Defocus DIMS for Moderate and High Myopia Control · Phase 1, PHASE2 · recruiting
- NCT07104513 — Efficacy and Influencing Factors of Repeated Low-level Red-light in Myopia · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07160036 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ruihua Wei
- Last refreshed: 15 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07160036.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing